The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Impel NeuroPharma announced the initiation of a Phase IIa study designed to explore the safety and pharmacodynamic effect of intranasal levodopa in ...
read more
BlueWillow Biologics announced the issuance of a U.S. patent entitled "Cancer Vaccine Compositions And Methods Of Using The Same," to the University ...
read more
JDRF announces the awarding of a research grant to International Diabetes Center (IDC) in Minneapolis.
read more
Wednesday, April 18, 2018
PharmaJet announced Vaccibody AS has received approval to start their cancer neoantigen trial using the PharmaJet Stratis needle-free injection system...
read more
Mylan has acquired global development and marketing rights from Prayog Labs to bring to market a fast-acting Meloxicam as a proposed non-narcotic ...
read more
The FDA issued an order to restrict the sale and distribution of the Essure device.
read more
Indivior announced that its U.S. subsidiary has filed patent lawsuits against Dr. Reddy's, Actavis, Par, Alvogen and Teva for infringement of United ...
read more
The FDA approved Sanofi's Toujeo Max SoloStar, the highest capacity long-acting insulin pen that will be available on the market.
read more
Amgen announced the CHMP of the EMA has adopted a positive opinion to include a new indication in the Repatha label for adults with established ...
read more
Genentech, Genentech, Inc.
Genentech announced the FDA approved the Lucentis 0.3 mg prefilled syringe (PFS) as a new method of administering the medicine to treat all forms of ...
read more
Wednesday, March 21, 2018
AOBiome Therapeutics announced clinical findings from Part 1 of a Phase 1b/2a clinical trial of the company's first-in-class Ammonia Oxidizing ...
read more
PharmaJet announced the reporting of positive interim results from the Phase 1 clinical trial conducted by the US Army Medical Research Institute of ...
read more
Ontario has become the first Canadian province to provide access to NARCAN Nasal Spray free of charge through pharmacies as part of its Ontario ...
read more
Tuesday, February 27, 2018
Amgen announced the CHMP of the EMA has issued a positive opinion recommending a label variation for Neulasta to include the Neulasta Onpro Kit.
read more
Wednesday, February 21, 2018
Biohaven has entered into an exclusive worldwide license agreement with Catalent to provide Zydis ODT for the development of Biohaven's lead CGRP ...
read more